These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7540636)

  • 21. Hepatocellular carcinoma coexistent with adenomatous hyperplasia: report of a case.
    Kurita K; Yoshida A; Tanabe G; Shirao K; Hamanoue M; Aikou T; Shimazu H
    Surg Today; 1993; 23(6):528-31. PubMed ID: 8395266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of transforming growth factor-alpha in hepatocellular carcinoma and focal nodular hyperplasia from European patients.
    Schaff Z; Hsia CC; Sarosi I; Tabor E
    Hum Pathol; 1994 Jul; 25(7):644-51. PubMed ID: 8026823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver cell dysplasia and hepatitis B surface antigen in liver cirrhosis and hepatocellular carcinoma.
    Akagi G; Furuya K; Kanamura A; Chihara T; Otsuka H
    Cancer; 1984 Jul; 54(2):315-8. PubMed ID: 6202391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma, adenoma, and focal nodular hyperplasia. Comparative histopathologic study with immunohistochemical parameters.
    Koelma IA; Nap M; Huitema S; Krom RA; Houthoff HJ
    Arch Pathol Lab Med; 1986 Nov; 110(11):1035-40. PubMed ID: 2430547
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of hyperplastic foci in livers with hepatocellular carcinomas by flow cytometry and AgNOR staining.
    Ikebe T; Wakasa K; Shuto T; Okuda T; Yamamoto T; Hirohashi K; Kinoshita H; Sakurai M
    Pathol Int; 1997 Aug; 47(8):547-52. PubMed ID: 9293535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural history and prognosis of adenomatous hyperplasia and early hepatocellular carcinoma: multi-institutional analysis of 53 nodules followed up for more than 6 months and 141 patients with single early hepatocellular carcinoma treated by surgical resection or percutaneous ethanol injection.
    Sakamoto M; Hirohashi S
    Jpn J Clin Oncol; 1998 Oct; 28(10):604-8. PubMed ID: 9839500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinicopathological significance of adenomatous hyperplasia of the liver].
    Nakashima O; Kojiro M
    Nihon Rinsho; 1994 Jan; 52(1):75-9. PubMed ID: 8114314
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression of breast cancer resistance protein in liver cirrhosis, hepatocellular carcinoma and peritumoral tissues].
    Wang YM; Huang GS; Hui YP; Zhang J
    Zhonghua Gan Zang Bing Za Zhi; 2009 Mar; 17(3):227-9. PubMed ID: 19335991
    [No Abstract]   [Full Text] [Related]  

  • 29. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenomatous hyperplasia of the liver resembling focal nodular hyperplasia in patients with chronic liver disease.
    Terada T; Kitani S; Ueda K; Nakanuma Y; Kitagawa K; Masuda S
    Virchows Arch A Pathol Anat Histopathol; 1993; 422(3):247-52. PubMed ID: 8388137
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of cytokeratin 19-positive biliary cells in cirrhotic nodules, hepatic borderline nodules (atypical adenomatous hyperplasia), and small hepatocellular carcinomas.
    Terada T; Hoso M; Nakanuma Y
    Mod Pathol; 1995 May; 8(4):371-9. PubMed ID: 7567933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tc-99m MIBI SPECT is useful for noninvasively predicting the presence of MDR1 gene-encoded P-glycoprotein in patients with hepatocellular carcinoma.
    Kim YS; Cho SW; Lee KJ; Hahm KB; Wang HJ; Yim H; Jin YM; Park CH
    Clin Nucl Med; 1999 Nov; 24(11):874-9. PubMed ID: 10551471
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study.
    Kaji K; Terada T; Nakanuma Y
    Am J Gastroenterol; 1994 Jun; 89(6):903-8. PubMed ID: 8198103
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term follow-up study of adenomatous hyperplasia in liver cirrhosis.
    Lencioni R; Caramella D; Bartolozzi C; Di Coscio G
    Ital J Gastroenterol; 1994 May; 26(4):163-8. PubMed ID: 7524802
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A triple stain of reticulin, glypican-3, and glutamine synthetase: a useful aid in the diagnosis of liver lesions.
    Swanson BJ; Yearsley MM; Marsh W; Frankel WL
    Arch Pathol Lab Med; 2015 Apr; 139(4):537-42. PubMed ID: 25822763
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential diagnosis of hepatocellular nodular lesions.
    Hytiroglou P; Theise ND
    Semin Diagn Pathol; 1998 Nov; 15(4):285-99. PubMed ID: 9845429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of P-glycoprotein and p53 in advanced hepatocellular carcinoma treated by single agent chemotherapy: clinical correlation.
    Chou YY; Cheng AL; Hsu HC
    J Gastroenterol Hepatol; 1997 Aug; 12(8):569-75. PubMed ID: 9304508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathological and immunohistochemical analysis of adenomatous hyperplasia and hepatocellular carcinoma: cellularity, thickness of cell cord, and Ki-67 proliferative activity.
    Than KW; Okayasu I; Akashi T
    Bull Tokyo Med Dent Univ; 1995 Jun; 42(2):67-81. PubMed ID: 7540960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical detection of ras oncogene p21 product in liver cirrhosis and hepatocellular carcinoma.
    Nonomura A; Ohta G; Hayashi M; Izumi R; Watanabe K; Takayanagi N; Mizukami Y; Matsubara F
    Am J Gastroenterol; 1987 Jun; 82(6):512-8. PubMed ID: 3034055
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging.
    Matsui O; Kadoya M; Kameyama T; Yoshikawa J; Arai K; Gabata T; Takashima T; Nakanuma Y; Terada T; Ida M
    Radiology; 1989 Oct; 173(1):123-6. PubMed ID: 2550995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.